TENULI
Live / Registered — Registered (as of 07 Apr 2026)
What this means for you
Registered since 07 Apr 2026. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 07 Apr 2032: the §71 affidavit of use).
Record
- Serial number
- 79429970
- Registration number
- 8200422
- Mark type
- Word mark
- Filed
- 11 Jul 2025
- Published for opposition
- 17 Feb 2026
- Registered
- 07 Apr 2026
- Next maintenance filing
- §71 affidavit of use, due by 07 Apr 2032 (grace period to 07 Oct 2032)
- Attorney of record
- Jeremy Blackowicz
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of blood conditions, diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditions, diseases, and disorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of endocrine conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of hepatic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of immunological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of metabolic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of muscular conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of neurological conditions, diseases, and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of renal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of urological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of viral diseases.
Owner
Prosecution history
- 01 Oct 2026 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 14 Sept 2026 — FINAL DISPOSITION NOTICE SENT TO IB
- 14 Sept 2026 — FINAL DISPOSITION PROCESSED
- 07 Jul 2026 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 07 Apr 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 07 Apr 2026 — REGISTERED-PRINCIPAL REGISTER
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Jan 2026 — REFUSAL PROCESSED BY IB
- 22 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 13 Jan 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 13 Jan 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 13 Jan 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Jan 2026 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB